ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Capital Increase
12.01.2009
Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Berlin, 12th January 2009. The Board of Directors at Eckert & Ziegler
Strahlen- und Medizintechnik AG (ISIN DE 0005659700) has resolved today
with the consent of the Supervisory Board to implement a capital increase
for cash with a partial utilisation of the approved capital in volumes of
up to 628,633 new shares. With the expected funds inflow parts of the
purchase price and the net current assets are to be financed in connection
with the acquisition of a competitor. As announced on 22 December 2008
Eckert & Ziegler acquired the buyers option.
The shareholders of the company will be granted a purchase right. Trading
the purchase rights via the stock exchange is not possible. The new shares
will not be permitted to be traded on the regulated market until further
notice so that no stock market trading will take place. The company intends
to effect the listing of the new shares at a later date. Linked to this is
the prior establishment and approval of a securities prospectus according
to the regulations of the Securities Prospectus Act. BankM, representation
of biw Bank für Investments und Wertpapiere AG, has been commissioned with
monitoring the capital increase.
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
An interview with the Chairman of the Board, Dr. Andreas Eckert, on the
topic of capital increase will be published at www.ezag.de.
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax 112
E-Mail: karolin.riehle@ezag.de, www.ezag.de
DGAP 12.01.2009
---------------------------------------------------------------------------
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf
End of News DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: Eckert & Ziegler resolves capital increase
| Source: EQS Group AG